TIGIT and neoplasm: These findings demonstrate that the NK cell–associated TIGIT signaling pathway has a role in tumors' evasion of the immune system and that reversing NK cell exhaustion is critical for the therapeutic effects of anti-tumor immunotherapy based on the blockade of TIGIT (239).